Free consultation:
(Mon. - Fri.: 09:00 - 18:00)

Exoskeleton Idego Parker: lightweight exoskeleton for gait therapy

Parker's devices are FDA-approved lower limb exoskeletons that provide task-specific, above-ground gait training to patients with lower extremity weakness or paralysis

Your three tangible benefits:

  • Long operating time
  • Only 18 kg
  • Fast donning and doffing

Functions and advantages

Everything you need to know about the features and benefits of the Indego Parker: lightweight exoskeleton for gait therapy need to know.


Each part of the exoskeleton can be customized to meet the patient's needs. Patients' body measurements are taken to ensure that the exoskeleton fits perfectly. The various control algorithms of the controller are based on principles of motor learning and enable an individualized, patient-centered training approach. Various adjustment options allow the exoskeleton to be adapted to the patient's needs, thus achieving the best possible therapy. The exoskeleton is designed to support patients' existing walking function and help them only when they need it. Intuitive controls and body signal processing allow for easy operation, supported by LED signals. Indego is a lightweight, modular construction kit that offers the best user experience.



Extremely light

Weighing just 12 kilograms, Indego boasts a sleek design with no visible cables and no bulky backpack components.



Due to its numerous functions, Indego is not only recommended as a therapy device, but also as a mobility support for personal use. Indego is an intensive and task-oriented gait training for therapists, which provides a new dimension of mobility and independence for persons with walking disabilities.

  • Quick donning and doffing
  • Light weight, slim and modular design
  • Extended power
  • Intelligent signal processing and control
  • Natural movement
  • Change of training parameters and documentation of progress control
  • App usable
  • Also portable in a wheelchair
  • Suitable for indoor and outdoor
  • For example to sit in the car usable
Technical details

Technical data


Rechargeable and replaceable Lition battery provides several hours of continuous operating time

One Indego incl. battery weighs 11.8 kg

Small: 21.6 x 45.7 x 109 cm
Medium: 22.9 x 47 x 117 cm
Large: 23.5 x 49.5 x 122 cm

Feedback to the user by means of vibratory feedback and visual signals via LEDs

Device settings can be checked and changed via an Indego app


Patients requirements


Body height: 155 - 191 cm
Maximum body weight: 113 kg
Maximum hip width: 42.2 cm
Femur length: 35 - 47 cm
Paralysis level: C5 or lower
Spasticity: Modified Ashworth score 3 or lower
Sufficient upper body strength to operate walking aids such as crutches or a walker Range of use

Temperature range: 0 ° - 40 °Celsius
Relative humidity: 30% - 75%

An Indego Clinical Kit consists of three Indego devices in the sizes small, medium and large, three batteries with charging station, padding material and two hand control units.


This novel device is unique in Germany and offers many advantages due to its modular design and its low weight of 18 kilograms. The new device is perfect for every patient and enables efficient gait therapy. In order for the exoskeleton to be perfectly adapted to the body, the patient's body measurements are first scanned. Each part of the exoskeleton is customized to provide the patient with the best possible comfort. The control system is based on various control algorithms that are based on principles of motor learning. This enables an individualized, patient-centered training approach: the exoskeleton responds to the patient's existing gait function and supports their gait only when needed. In addition, therapists have various adjustment options at their disposal to address specific patient impairments and achieve therapy goals in the best possible way.

For whom suitable and for whom not?

Indego Therapy is FDA approved for use in patients with spinal cord injuries at injury levels C7 through L5 and for individuals with hemiplegia (with motor function of 4/5 in at least one upper extremity) due to a cerebrovascular accident (CVA) to perform outpatient functions in rehabilitation facilities. Indego Personal is FDA-approved to enable individuals with spinal cord injuries at levels T3 through L5 to perform outpatient functions in their homes and communities. Indego Therapy and Indego Personal are also available in Europe, having received CE marking in November 2015.


The Ekso Indego Therapy is a powered lower extremity exoskeleton that can be easily adapted to individual patient needs within five minutes. It comes with a comprehensive software suite that provides various options, settings and analytics to track patient and device performance in real time. Therapists can use this data to optimize treatment plans and provide specific gait training for individual tasks. The Ekso Indego Therapy enables over-the-floor training, making it an ideal solution for patients with limited mobility.

FAQ - Frequently asked questions

What is Indego?

Indego is the name of a powered leg orthosis, also known as an exoskeleton. The motorized hip and knee joints, combined with sensor technology and intelligent control, can enable people with walking disabilities to stand and walk.

Is there an app? What use is the Indego app?

The Indego app on your mobile device makes it easy to control operation and change settings - all wirelessly. Thanks to the Indego app on your mobile device, you can easily control and change everything wirelessly.

Do you have any questions?

Can't find the answer to your question? Contact us.

For whom is the Indego exoskeleton suitable and for whom not?

The Parker Indego Exoskeleton can be used in rehabilitation clinics as a novel therapy solution, as well as at home for mobility support.


Primary Focus:


  • For people with walking disabilities
  • Paraplegia
  • Stroke
  • Multiple sclerosis


As a therapy device, Indego enables therapists to perform intensive and task-oriented gait training .

Company information

Facts & Figures

The company was founded in 2015 and is based in Hamburg, Germany. Ekso Bionics acquires the exoskeleton, human motion and control businesses of Parker Hannifin (Indego). Ekso Bionics has raised a total of $187.9 million in 13 rounds of financing. The most recent financing was on February 11, 2021, in a post-IPO equity round.Ekso Bionics is registered under the ticker NASDAQ:EKSO. Ekso Bionics is funded by 5 investors. Bridge Bank and Montrose Capital Partners are the latest investors.

Company address

  • Ekso Bionics Europe GmbH
  • Friesenweg 20
  • 22763 Hamburg

By loading the video, you accept YouTube's privacy policy.
Learn more

Load video

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
Request more information

It applies our Privacy policy.


By loading the video, you accept YouTube's privacy policy.
Learn more

Load video